{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:31:08Z","timestamp":1787725868946,"version":"build-2784847793"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum M\u00fcnster"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/Aims<\/jats:title>\n                    <jats:p>Acute-on-chronic liver failure (ACLF) is one of the deadliest complications of chronic liver disease yet treatment options are sparse. In Asia, HBV-reactivation (HBVr) is one of the most common triggers. Recently, HBV-associated ACLF was associated with distinct changes in the metabolome. Here, metabolic impacts of HBVr were analysed in-depth in non-ACLF, pre-ACLF and ACLF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical and metabolic data of 1024 Chinese patients (CATCH-LIFE studies) with chronic HBV mono-infection were analyzed. ACLF was diagnosed according to COSSH criteria. Metabolites in plasma were quantified using LC-MS, compared to non-ACLF and subjected to enrichment and pathway analyses using the database SMPDB via MetaboAnalyst v6.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 1024 patients (611: non-ACLF, 72: pre-ACLF, 341: ACLF), HBVr was present in 20.2% (ACLF) or 33.3% (pre-ACLF) of patients. HBVr increased 28-day mortality in pre-ACLF patients (2.1% in HBVnr vs. 25% in HBVr). Energy metabolism generating reactive oxygen species (ROS) was highly induced in the absence of ROS-detoxifying pathways in pre-ACLF. Urea cycle, thus nitric oxide (NO) build-up, the polyamine metabolism and related pathways were highly increased in both HBVr pre-ACLF and ACLF, shifting pre-ACLF close to mature ACLF. Specific metabolites could be identified as putative markers and key-regulators herein.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HBV reactivation induces inflammation, hepatic injury and mortality especially in pre-ACLF patients. Metabolic disruption in the ROS\/NO\/polyamine axis favors stress and hinders liver regeneration. Findings help identifying and alleviating HBVr-driven progression towards ACLF via pharmacological or biopharmaceutical intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Analyses were based on the CATCH-LIFE studies. The CATCH-LIFE studies were registered at Clinical.trials.gov (Clinical Trial Number: NCT02457637, first registered 2015-01-31 and NCT03641872, first registered 2018-08-14).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-026-03145-y","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:30:33Z","timestamp":1787574633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HBV re-activation is associated with increased mortality and dysregulation of oxidative and polyamine metabolism in pre-acute-on-chronic liver failure"],"prefix":"10.1186","volume":"24","author":[{"given":"Mirco","family":"Glitscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerthihan","family":"Thiyagarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannik","family":"Sonnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Lembeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Grammatikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lining","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongji","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Hildt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3757-4476","authenticated-orcid":false,"given":"Kai-Henrik","family":"Peiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"issue":"2","key":"3145_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/v1020185","volume":"1","author":"S Schadler","year":"2009","unstructured":"Schadler S, Hildt E. HBV life cycle: entry and morphogenesis. Viruses. 2009;1(2):185\u2013209.","journal-title":"Viruses"},{"key":"3145_CR2","unstructured":"WHO. Global hepatitis report 2024: Action for access in low and middle-income countries. https:\/\/www.who.int\/publications\/i\/item\/9789240091672 Accessed 30 Oct 2024."},{"issue":"1","key":"3145_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hep Intl. 2016;10(1):1\u201398.","journal-title":"Hep Intl"},{"issue":"2","key":"3145_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","volume":"83","author":"European Association for the Study of the L","year":"2025","unstructured":"European Association for the Study of the L. EASL Clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2025;83(2):502\u201383.","journal-title":"J Hepatol"},{"issue":"4","key":"3145_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hep Intl. 2019;13(4):353\u201390.","journal-title":"Hep Intl"},{"issue":"2","key":"3145_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","volume":"79","author":"European Association for the Study of the Liver","year":"2023","unstructured":"European Association for the Study of the Liver. Electronic address eee, European association for the study of the L. EASL clinical practice guidelines on acute-on-chronic liver failure. J Hepatol. 2023;79(2):461\u201391.","journal-title":"J Hepatol"},{"issue":"12","key":"3145_CR7","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","volume":"67","author":"T Wu","year":"2018","unstructured":"Wu T, Li J, Shao L, Xin J, Jiang L, Zhou Q, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 2018;67(12):2181\u201391.","journal-title":"Gut"},{"issue":"1","key":"3145_CR8","doi-asserted-by":"publisher","first-page":"100176","DOI":"10.1016\/j.jhepr.2020.100176","volume":"3","author":"G Zaccherini","year":"2021","unstructured":"Zaccherini G, Weiss E, Moreau R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment. JHEP Rep. 2021;3(1):100176.","journal-title":"JHEP Rep"},{"issue":"4","key":"3145_CR9","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","volume":"73","author":"J Trebicka","year":"2020","unstructured":"Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C, et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol. 2020;73(4):842\u201354.","journal-title":"J Hepatol"},{"issue":"7","key":"3145_CR10","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426\u201337.","journal-title":"Gastroenterology"},{"issue":"5","key":"3145_CR11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jhep.2020.11.019","volume":"74","author":"J Trebicka","year":"2021","unstructured":"Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C, et al. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. J Hepatol. 2021;74(5):1097\u2013108.","journal-title":"J Hepatol"},{"issue":"5","key":"3145_CR12","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s12072-021-10239-x","volume":"15","author":"G Lau","year":"2021","unstructured":"Lau G, Yu ML, Wong G, Thompson A, Ghazinian H, Hou JL, et al. APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy. Hep Intl. 2021;15(5):1031\u201348.","journal-title":"Hep Intl"},{"issue":"4","key":"3145_CR13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","volume":"72","author":"R Moreau","year":"2020","unstructured":"Moreau R, Claria J, Aguilar F, Fenaille F, Lozano JJ, Junot C, et al. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. J Hepatol. 2020;72(4):688\u2013701.","journal-title":"J Hepatol"},{"issue":"5","key":"3145_CR14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jhep.2023.07.011","volume":"79","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Tan W, Wang X, Zheng X, Huang Y, Li B, et al. Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes. J Hepatol. 2023;79(5):1159\u201371.","journal-title":"J Hepatol"},{"issue":"1","key":"3145_CR15","doi-asserted-by":"publisher","first-page":"e037793","DOI":"10.1136\/bmjopen-2020-037793","volume":"11","author":"L Qiao","year":"2021","unstructured":"Qiao L, Wang X, Deng G, Huang Y, Chen J, Meng Z, et al. Cohort profile: a multicentre prospective validation cohort of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study. BMJ Open. 2021;11(1):e037793.","journal-title":"BMJ Open"},{"issue":"D1","key":"3145_CR16","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart DS, Guo A, Oler E, Wang F, Anjum A, Peters H, et al. HMDB 5.0: the Human Metabolome Database for 2022. Nucleic Acids Res. 2022;50(D1):D622\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"3145_CR17","doi-asserted-by":"publisher","first-page":"D478","DOI":"10.1093\/nar\/gkt1067","volume":"42","author":"T Jewison","year":"2014","unstructured":"Jewison T, Su Y, Disfany FM, Liang Y, Knox C, Maciejewski A, et al. SMPDB 2.0: big improvements to the small molecule pathway database. Nucleic Acids Res. 2014;42(Database issue):D478\u201384.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"3145_CR18","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang Z, Lu Y, Zhou G, Hui F, Xu L, Viau C, et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 2024;52(W1):W398\u2013406.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"3145_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/bioinformatics\/btr671","volume":"30","author":"Y Xiao","year":"2014","unstructured":"Xiao Y, Hsiao TH, Suresh U, Chen HI, Wu X, Wolf SE, et al. A novel significance score for gene selection and ranking. Bioinformatics. 2014;30(6):801\u20137.","journal-title":"Bioinformatics"},{"key":"3145_CR20","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.2147\/IDR.S402585","volume":"16","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yang K, Wang Q, Jin L, Wang LM, Fan XY, et al. Prealbumin as a predictor of short-term prognosis in patients with HBV-related acute-on-chronic liver failure. Infect Drug Resist. 2023;16:2611\u201323.","journal-title":"Infect Drug Resist"},{"issue":"5","key":"3145_CR21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jhep.2021.06.043","volume":"75","author":"J Claria","year":"2021","unstructured":"Claria J, Curto A, Moreau R, Colsch B, Lopez-Vicario C, Lozano JJ, et al. Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis. J Hepatol. 2021;75(5):1116\u201327.","journal-title":"J Hepatol"},{"issue":"8","key":"3145_CR22","doi-asserted-by":"publisher","first-page":"e104988","DOI":"10.1371\/journal.pone.0104988","volume":"9","author":"F Qu","year":"2014","unstructured":"Qu F, Zheng SJ, Liu S, Wu CS, Duan ZP, Zhang JL. Serum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failure. PLoS ONE. 2014;9(8):e104988.","journal-title":"PLoS ONE"},{"issue":"2","key":"3145_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41590-017-0013-y","volume":"19","author":"C Holze","year":"2018","unstructured":"Holze C, Michaudel C, Mackowiak C, Haas DA, Benda C, Hubel P, et al. Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway. Nat Immunol. 2018;19(2):130\u201340.","journal-title":"Nat Immunol"},{"issue":"6","key":"3145_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1159\/000533296","volume":"9","author":"D Luo","year":"2023","unstructured":"Luo D, Lu X, Li Y, Xu Y, Zhou Y, Mao H. Metabolism of polyamines and kidney disease: a promising therapeutic target. Kidney Dis (Basel). 2023;9(6):469\u201384.","journal-title":"Kidney Dis (Basel)"},{"key":"3145_CR25","doi-asserted-by":"publisher","first-page":"1161542","DOI":"10.3389\/fphar.2023.1161542","volume":"14","author":"H Peng","year":"2023","unstructured":"Peng H, Zhu M, Kong W, Tang C, Du J, Huang Y, et al. L-cystathionine protects against oxidative stress and DNA damage induced by oxidized low-density lipoprotein in THP-1-derived macrophages. Front Pharmacol. 2023;14:1161542.","journal-title":"Front Pharmacol"},{"key":"3145_CR26","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1038\/srep08421","volume":"5","author":"H Li","year":"2015","unstructured":"Li H, Zhu W, Zhang L, Lei H, Wu X, Guo L, et al. The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci Rep. 2015;5:8421.","journal-title":"Sci Rep"},{"key":"3145_CR27","doi-asserted-by":"crossref","unstructured":"Bender D, Hildt E. Effect of Hepatitis Viruses on the Nrf2\/Keap1-Signaling pathway and its impact on viral replication and pathogenesis. Int J Mol Sci. 2019;20(18):4659.","DOI":"10.3390\/ijms20184659"},{"issue":"4","key":"3145_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.freeradbiomed.2009.11.012","volume":"48","author":"EE Kelley","year":"2010","unstructured":"Kelley EE, Khoo NK, Hundley NJ, Malik UZ, Freeman BA, Tarpey MM. Hydrogen peroxide is the major oxidant product of xanthine oxidase. Free Radic Biol Med. 2010;48(4):493\u20138.","journal-title":"Free Radic Biol Med"},{"issue":"15","key":"3145_CR29","doi-asserted-by":"publisher","first-page":"15460","DOI":"10.1074\/jbc.M309280200","volume":"279","author":"YI Lee","year":"2004","unstructured":"Lee YI, Hwang JM, Im JH, Lee YI, Kim NS, Kim DG, et al. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J Biol Chem. 2004;279(15):15460\u201371.","journal-title":"J Biol Chem"},{"issue":"5","key":"3145_CR30","doi-asserted-by":"publisher","first-page":"e0042424","DOI":"10.1128\/jvi.00424-24","volume":"98","author":"A Schollmeier","year":"2024","unstructured":"Schollmeier A, Basic M, Glitscher M, Hildt E. The impact of HBx protein on mitochondrial dynamics and associated signaling pathways strongly depends on the hepatitis B virus genotype. J Virol. 2024;98(5):e0042424.","journal-title":"J Virol"},{"key":"3145_CR31","doi-asserted-by":"publisher","first-page":"197842","DOI":"10.1016\/j.virusres.2019.197842","volume":"277","author":"KB Hwang","year":"2020","unstructured":"Hwang KB, Kyaw YY, Kang HR, Seong MS, Cheong J. Mitochondrial dysfunction stimulates HBV gene expression through lipogenic transcription factor activation. Virus Res. 2020;277:197842.","journal-title":"Virus Res"},{"issue":"52","key":"3145_CR32","doi-asserted-by":"publisher","first-page":"41074","DOI":"10.1074\/jbc.M110.145862","volume":"285","author":"S Schaedler","year":"2010","unstructured":"Schaedler S, Krause J, Himmelsbach K, Carvajal-Yepes M, Lieder F, Klingel K, et al. Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2. J Biol Chem. 2010;285(52):41074\u201386.","journal-title":"J Biol Chem"},{"issue":"12","key":"3145_CR33","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1210\/en.2003-0982","volume":"144","author":"DG Hardie","year":"2003","unstructured":"Hardie DG. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology. 2003;144(12):5179\u201383.","journal-title":"Endocrinology"},{"issue":"1","key":"3145_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41467-020-20316-8","volume":"12","author":"L Zhou","year":"2021","unstructured":"Zhou L, He R, Fang P, Li M, Yu H, Wang Q, et al. Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition. Nat Commun. 2021;12(1):98.","journal-title":"Nat Commun"},{"issue":"8","key":"3145_CR35","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","volume":"56","author":"K Czubowicz","year":"2019","unstructured":"Czubowicz K, Jesko H, Wencel P, Lukiw WJ, Strosznajder RP. The role of ceramide and sphingosine-1-phosphate in alzheimer\u2019s disease and other neurodegenerative disorders. Mol Neurobiol. 2019;56(8):5436\u201355.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"3145_CR36","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/hep4.1561","volume":"4","author":"VT Mucke","year":"2020","unstructured":"Mucke VT, Maria Schwarzkopf K, Thomas D, Mucke MM, Ruschenbaum S, Trebicka J, et al. Serum sphingosine-1-phosphate is decreased in patients with acute-on-chronic liver failure and predicts early mortality. Hepatol Commun. 2020;4(10):1477\u201386.","journal-title":"Hepatol Commun"},{"key":"3145_CR37","doi-asserted-by":"publisher","first-page":"109680","DOI":"10.1016\/j.cbi.2021.109680","volume":"349","author":"VI Lushchak","year":"2021","unstructured":"Lushchak VI, Lushchak O. Interplay between reactive oxygen and nitrogen species in living organisms. Chem Biol Interact. 2021;349:109680.","journal-title":"Chem Biol Interact"},{"issue":"4","key":"3145_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.thromres.2006.11.008","volume":"120","author":"MG Signorello","year":"2007","unstructured":"Signorello MG, Viviani GL, Armani U, Cerone R, Minniti G, Piana A, et al. Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res. 2007;120(4):607\u201313.","journal-title":"Thromb Res"},{"issue":"5","key":"3145_CR39","first-page":"727","volume":"64","author":"HD Zhu","year":"2018","unstructured":"Zhu HD, Ma YC. Serum homocysteine as a prognostic biomarker for short-term mortality in HBV-related acute-on-chronic liver failure patients. Clin Lab. 2018;64(5):727\u201333.","journal-title":"Clin Lab"},{"issue":"1","key":"3145_CR40","doi-asserted-by":"publisher","first-page":"6932","DOI":"10.1038\/s41598-017-07112-z","volume":"7","author":"S Chen","year":"2017","unstructured":"Chen S, Dong Z, Zhao Y, Sai N, Wang X, Liu H, et al. Homocysteine induces mitochondrial dysfunction involving the crosstalk between oxidative stress and mitochondrial pSTAT3 in rat ischemic brain. Sci Rep. 2017;7(1):6932.","journal-title":"Sci Rep"},{"issue":"5","key":"3145_CR41","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S1665-2681(19)31436-X","volume":"11","author":"CE Carnovale","year":"2012","unstructured":"Carnovale CE, Ronco MT. Role of nitric oxide in liver regeneration. Ann Hepatol. 2012;11(5):636\u201347.","journal-title":"Ann Hepatol"},{"issue":"Pt 1","key":"3145_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1042\/bj3620149","volume":"362","author":"L Alhonen","year":"2002","unstructured":"Alhonen L, Rasanen TL, Sinervirta R, Parkkinen JJ, Korhonen VP, Pietila M, et al. Polyamines are required for the initiation of rat liver regeneration. Biochem J. 2002;362(Pt 1):149\u201353.","journal-title":"Biochem J"},{"issue":"1","key":"3145_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","volume":"6","author":"MD Michael","year":"2000","unstructured":"Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell. 2000;6(1):87\u201397.","journal-title":"Mol Cell"},{"issue":"2","key":"3145_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.tips.2010.11.006","volume":"32","author":"T Tiganis","year":"2011","unstructured":"Tiganis T. Reactive oxygen species and insulin resistance: the good, the bad and the ugly. Trends Pharmacol Sci. 2011;32(2):82\u20139.","journal-title":"Trends Pharmacol Sci"},{"issue":"42","key":"3145_CR45","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.3748\/wjg.v18.i42.6120","volume":"18","author":"JG Lee","year":"2012","unstructured":"Lee JG, Lee S, Kim YJ, Cho BM, Park JS, Kim HH, et al. Association of chronic viral hepatitis B with insulin resistance. World J gastroenterology: WJG. 2012;18(42):6120\u20136.","journal-title":"World J gastroenterology: WJG"},{"issue":"21","key":"3145_CR46","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1007\/s00018-016-2259-1","volume":"73","author":"SR Barthel","year":"2016","unstructured":"Barthel SR, Medvedev R, Heinrich T, Buchner SM, Kettern N, Hildt E. Hepatitis B virus inhibits insulin receptor signaling and impairs liver regeneration via intracellular retention of the insulin receptor. Cell Mol Life Sci. 2016;73(21):4121\u201340.","journal-title":"Cell Mol Life Sci"},{"issue":"23","key":"3145_CR47","doi-asserted-by":"publisher","first-page":"13829","DOI":"10.1073\/pnas.95.23.13829","volume":"95","author":"RM Rai","year":"1998","unstructured":"Rai RM, Lee FY, Rosen A, Yang SQ, Lin HZ, Koteish A, et al. Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. Proc Natl Acad Sci USA. 1998;95(23):13829\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"3145_CR48","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1023\/A:1026631230611","volume":"44","author":"N Barak","year":"1999","unstructured":"Barak N, Zemel R, Ben-Ari Z, Braun M, Tur-Kaspa R. Nitric oxide metabolites in decompensated liver cirrhosis. Dig Dis Sci. 1999;44(7):1338\u201341.","journal-title":"Dig Dis Sci"},{"key":"3145_CR49","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.2147\/IJGM.S379837","volume":"15","author":"F Wang","year":"2022","unstructured":"Wang F, Tai M, He Y, Tian Z. Serum Nitric Oxide Level Serves as a Potential Prognostic Biomarker in ACLF Patients. Int J Gen Med. 2022;15:6713\u201323.","journal-title":"Int J Gen Med"},{"issue":"6","key":"3145_CR50","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1053\/jhep.2001.29626","volume":"34","author":"P Majano","year":"2001","unstructured":"Majano P, Lara-Pezzi E, Lopez-Cabrera M, Apolinario A, Moreno-Otero R, Garcia-Monzon C. Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappaB-binding site: evidence that cytoplasmic location of X protein is essential for gene transactivation. Hepatology. 2001;34(6):1218\u201324.","journal-title":"Hepatology"},{"issue":"1","key":"3145_CR51","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13073-016-0318-8","volume":"8","author":"JC Schoeman","year":"2016","unstructured":"Schoeman JC, Hou J, Harms AC, Vreeken RJ, Berger R, Hankemeier T, et al. Metabolic characterization of the natural progression of chronic hepatitis B. Genome Med. 2016;8(1):64.","journal-title":"Genome Med"},{"key":"3145_CR52","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fcimb.2020.00158","volume":"10","author":"B Mao","year":"2020","unstructured":"Mao B, Wang Z, Pi S, Long Q, Chen K, Cui J, et al. Difluoromethylornithine, a decarboxylase 1 Inhibitor, suppresses hepatitis B virus replication by reducing HBc protein levels. Front Cell Infect Microbiol. 2020;10:158.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03145-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03145-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03145-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:02:34Z","timestamp":1787724154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-03145-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3145"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-03145-y","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients and volunteers were adequately informed, and written consent was obtained from the study subjects or the legal surrogates of the patients before enrolment. The research was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"460"}}